Thermo Fisher Scientific | TMO - Debt


Thermo Fisher Scientific reported $39.39B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Abbott USD 13.86B 919M Dec/2025
Agilent USD 3.35B 0 Dec/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Bio Techne USD 200M 60M Mar/2026
Bio-Rad Laboratories USD 1.39B 9.2M Dec/2025
Boston Scientific USD 11.44B 610M Dec/2025
Bruker USD 2.04B 34.4M Dec/2025
Charles River Laboratories USD 2.57B 58.23M Dec/2025
Danaher USD 18.48B 66M Mar/2026
Dentsply International USD 2.33B 137M Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
General Electric Aerospace USD 20.28B 217M Mar/2026
Henry Schein USD 3.75B 313M Mar/2026
Illumina USD 2.55B 23M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 15.83B 109M Mar/2026
Laboratory Of America USD 6.53B 3.9M Dec/2025
Medtronic USD 28.07B 1.03B Dec/2025
Mettler Toledo International USD 2.15B 57.69M Dec/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Olympus JPY 233.87B 4.77B Sep/2025
OraSure Technologies USD 782K 465K Jun/2024
Quest Diagnostics USD 6.41B 179M Mar/2026
Repligen USD 546.58M 4.37M Mar/2026
Revvity USD 3.4B 29.2M Dec/2025
Stryker USD 14.22B 635M Mar/2026
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Veracyte USD 39.65M 799K Dec/2025
Waters USD 1.49B 4.92M Dec/2025
Zimmer Biomet Holdings USD 7.47B 48.1M Mar/2026